Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105492606A enables efficient (-)-vibo-quercitol production via novel reductase, offering high purity and cost reduction for pharma intermediates.
Patent CN110129306A details immobilized transaminase for besifloxacin intermediates. Offers high purity, reusability, and scalable manufacturing solutions for global pharmaceutical supply chains.
Novel hydroxylase method reduces cis-3-hydroxy impurity for pharmaceutical intermediates. Scalable biocatalysis ensures cost efficiency and supply reliability.
Discover a novel synthetic route for Tolterodine intermediates utilizing safe borohydride reduction. This patent-based analysis highlights significant cost reduction and scalable manufacturing advantages for pharmaceutical supply chains.
Patent CN106905336B reveals mild organocatalytic route for high-purity chiral pyrazole spirofuran intermediates, offering cost-effective scale-up for pharmaceutical manufacturing.
Patent CN111484962B enables efficient 5α-AD production via engineered Mycobacterium. Discover cost reduction in steroid manufacturing and reliable supply chain solutions.
Patent CN112110951B discloses a novel aqueous radical coupling method for Bryostatin C-ring skeletons, offering cost reduction in API manufacturing and scalable production.
Patent CN101759602B details non-phosgene route enhancing purity and supply chain stability for global carbamate intermediate procurement strategies.
Patent CN111482178A details a continuous fixed-bed process for chloroquine intermediates using supported nano-nickel, offering high purity and reduced environmental impact for reliable supply chains.
Patent CN112121848A reveals advanced purification for 3-methyl-2-buten-1-ol, ensuring high purity and catalyst longevity for cost-effective agrochemical and pharma manufacturing.
Patent CN108893455A details a transaminase mutant for L-glufosinate-ammonium production. Achieves 98% yield and 99% ee. Ideal for agrochemical intermediate supply chains seeking cost reduction.
Patent CN113336738A details a green synthesis route for shikimic acid ethers using recyclable cation exchange resins, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN105821090A details a novel NAD(H)-dependent StDapdh mutant for D-alanine synthesis, offering enhanced stability and cost-effective biocatalytic manufacturing solutions.
Patent CN1761640A details a novel bismuth-catalyzed oxidative cleavage of vic-diols, offering a safer, high-yield route for agrochemical intermediates and fine chemicals.
Novel alkaline ionic liquid catalyst enables efficient synthesis. Reduced cost and enhanced supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN1304356C enables efficient reductive dehalogenation for quinolone intermediates. Offers cost reduction and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN106119272A reveals efficient enzymatic co-production reducing cofactor costs for pharmaceutical intermediate manufacturing supply chains and enhancing scalability.
Patent CN107759565B details a high-yield, chromatography-free synthesis of efinaconazole intermediates using lithium halides, offering significant cost and supply chain advantages.
Patent CN108546691B discloses a novel 7β-HSDH mutant utilizing cheap NADH for ursodeoxycholic acid production, offering significant cost reduction and scalable biocatalysis solutions.
Patent CN120097887A details a novel acid-catalyzed route converting sulfonamide inventory into high-value pyrrole compounds for cost-effective pharmaceutical intermediates manufacturing.